vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and REGIS CORP (RGS). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $57.1M, roughly 1.5× REGIS CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 0.8%, a 22.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 22.3%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $891.0K). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.8%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
FDMT vs RGS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $57.1M |
| Net Profit | $19.4M | $456.0K |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 10.8% |
| Net Margin | 22.8% | 0.8% |
| Revenue YoY | 8508900.0% | 22.3% |
| Net Profit YoY | 139.1% | -94.0% |
| EPS (diluted) | $0.43 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $57.1M | ||
| Q3 25 | $90.0K | $59.0M | ||
| Q2 25 | $15.0K | $60.4M | ||
| Q1 25 | $14.0K | $57.0M | ||
| Q4 24 | $1.0K | $46.7M | ||
| Q3 24 | $3.0K | $46.1M | ||
| Q2 24 | $5.0K | $49.4M | ||
| Q1 24 | $28.0K | $49.2M |
| Q4 25 | $19.4M | $456.0K | ||
| Q3 25 | $-56.9M | $1.4M | ||
| Q2 25 | $-54.7M | $116.5M | ||
| Q1 25 | $-48.0M | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $-43.8M | $-853.0K | ||
| Q2 24 | $-35.0M | $91.2M | ||
| Q1 24 | $-32.4M | $-2.3M |
| Q4 25 | 17.3% | 10.8% | ||
| Q3 25 | -67983.3% | 10.0% | ||
| Q2 25 | -396373.3% | 12.1% | ||
| Q1 25 | -383007.1% | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -1704400.0% | 4.6% | ||
| Q2 24 | -849120.0% | — | ||
| Q1 24 | -136200.0% | 8.3% |
| Q4 25 | 22.8% | 0.8% | ||
| Q3 25 | -63195.6% | 2.3% | ||
| Q2 25 | -364386.7% | 192.9% | ||
| Q1 25 | -342657.1% | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | -1461433.3% | -1.9% | ||
| Q2 24 | -699060.0% | 184.7% | ||
| Q1 24 | -115717.9% | -4.7% |
| Q4 25 | $0.43 | $0.16 | ||
| Q3 25 | $-1.01 | $0.49 | ||
| Q2 25 | $-0.98 | $43.67 | ||
| Q1 25 | $-0.86 | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | $-0.79 | $-0.36 | ||
| Q2 24 | $-0.63 | $38.40 | ||
| Q1 24 | $-0.66 | $-1.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $18.4M |
| Total DebtLower is stronger | — | $113.3M |
| Stockholders' EquityBook value | $505.7M | $188.7M |
| Total Assets | $566.7M | $588.3M |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $18.4M | ||
| Q3 25 | $305.1M | $16.6M | ||
| Q2 25 | $293.2M | $17.0M | ||
| Q1 25 | $321.4M | $13.3M | ||
| Q4 24 | $424.9M | $10.2M | ||
| Q3 24 | $501.9M | $6.3M | ||
| Q2 24 | $541.9M | $10.1M | ||
| Q1 24 | $525.9M | $5.9M |
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
| Q4 25 | $505.7M | $188.7M | ||
| Q3 25 | $369.0M | $187.6M | ||
| Q2 25 | $420.9M | $185.6M | ||
| Q1 25 | $469.7M | $68.6M | ||
| Q4 24 | $510.6M | $66.7M | ||
| Q3 24 | $552.9M | $56.4M | ||
| Q2 24 | $588.3M | $56.8M | ||
| Q1 24 | $600.6M | $-35.8M |
| Q4 25 | $566.7M | $588.3M | ||
| Q3 25 | $424.0M | $592.1M | ||
| Q2 25 | $473.6M | $599.0M | ||
| Q1 25 | $515.7M | $511.2M | ||
| Q4 24 | $560.4M | $530.1M | ||
| Q3 24 | $604.0M | $508.9M | ||
| Q2 24 | $620.1M | $530.5M | ||
| Q1 24 | $629.9M | $543.7M |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $1.7M |
| Free Cash FlowOCF − Capex | $28.5M | $891.0K |
| FCF MarginFCF / Revenue | 33.5% | 1.6% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.47× | 3.65× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $14.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $1.7M | ||
| Q3 25 | $-46.5M | $2.3M | ||
| Q2 25 | $-43.4M | $6.8M | ||
| Q1 25 | $-47.8M | $6.2M | ||
| Q4 24 | $-134.6M | $2.1M | ||
| Q3 24 | $-29.4M | $-1.3M | ||
| Q2 24 | $-30.2M | $5.1M | ||
| Q1 24 | $-29.1M | $-277.0K |
| Q4 25 | $28.5M | $891.0K | ||
| Q3 25 | $-46.6M | $1.9M | ||
| Q2 25 | $-43.4M | $6.2M | ||
| Q1 25 | $-48.4M | $5.9M | ||
| Q4 24 | $-138.4M | $1.7M | ||
| Q3 24 | $-31.2M | $-1.4M | ||
| Q2 24 | $-30.6M | $5.1M | ||
| Q1 24 | $-29.8M | $-326.0K |
| Q4 25 | 33.5% | 1.6% | ||
| Q3 25 | -51765.6% | 3.2% | ||
| Q2 25 | -289620.0% | 10.3% | ||
| Q1 25 | -345635.7% | 10.3% | ||
| Q4 24 | -13837100.0% | 3.6% | ||
| Q3 24 | -1038966.7% | -3.0% | ||
| Q2 24 | -611840.0% | 10.3% | ||
| Q1 24 | -106421.4% | -0.7% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 101.1% | 0.7% | ||
| Q2 25 | 440.0% | 0.9% | ||
| Q1 25 | 4507.1% | 0.6% | ||
| Q4 24 | 378600.0% | 0.9% | ||
| Q3 24 | 59266.7% | 0.0% | ||
| Q2 24 | 6980.0% | 0.0% | ||
| Q1 24 | 2535.7% | 0.1% |
| Q4 25 | 1.47× | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
